Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1976 Aug;10(2):288–292. doi: 10.1128/aac.10.2.288

In Vitro Evaluation of the New Oral Cephalosporin Cefatrizine: Comparison with Other Cephalosporins

C Caroline Blackwell *, Earl H Freimer *, Gregory C Tuke *
PMCID: PMC429737  PMID: 984771

Abstract

Cefatrizine (BL-S640), a semisynthetic, orally administered cephalosporin, was found to have an in vitro spectrum of activity comparable to those of four other cephalosporins tested. It is as effective as cephalexin, the other orally administered cephalosporin evaluated, against most species, and it appears to be more effective than cephalexin against many Enterobacter, Haemophilus, and Proteus strains isolated in our hospital. It is not inactivated by the plasmid-determined β-lactamases of 14 strains of ampicillin-resistant Salmonella typhimurium or the ampicillin resistance determinant of an H. influenza strain from the Center for Disease Control. No synergy was observed between cefatrizine and gentamicin, kanamycin, carbenicillin, or polymyxin when tested against selected strains.

Full text

PDF
288

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  2. Finland M. Oral and parenteral cephalosporins: the place of cephalexin in antibacterial therapy. Drugs. 1972;3(1):1–8. doi: 10.2165/00003495-197203010-00001. [DOI] [PubMed] [Google Scholar]
  3. Kayser F. H. In vitro activity of cephalosporin antibiotics against Gram-positive bacteria. Postgrad Med J. 1971 Feb;47(Suppl):14–20. [PubMed] [Google Scholar]
  4. Leitner F., Buck R. E., Misiek M., Pursiano T. A., Price K. E. BL-S 640, a cephalosporin with a broad spectrum of antibacterial activity: properties in vitro. Antimicrob Agents Chemother. 1975 Mar;7(3):298–305. doi: 10.1128/aac.7.3.298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Levison M. E., Johnson W. D., Thornhill T. S., Kaye D. Clinical and in vitro evaluation of cephalexin. A new orally administered cephalosporin antibiotic. JAMA. 1969 Sep 1;209(9):1331–1336. [PubMed] [Google Scholar]
  6. Overturf G. D., Ressler R. L., Marengo P. B., Wilkins J. In vitro evaluation of BL-S640, a new oral cephalosporin antibiotic. Antimicrob Agents Chemother. 1975 Sep;8(3):305–310. doi: 10.1128/aac.8.3.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Stilwell G. A., Adams H. G., Turck M. In vitro evaluation of a new oral cephalosporin, cefatrizine (BL-s640). Antimicrob Agents Chemother. 1975 Dec;8(6):751–753. doi: 10.1128/aac.8.6.751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Watanakunakorn C., Bannister T., Glotzbecker C. Susceptibility of clinical isolates of Enterobacteriaceae to BL-S640, a new oral cephalosporin. Antimicrob Agents Chemother. 1975 Mar;7(3):381–385. doi: 10.1128/aac.7.3.381. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES